|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2007-12-31 Purchase |
2008-01-04 08:48 am | MACROCHEM CORP | MACM.OB | LUCI DAVID P (Vice President) | 3,000 | $0.59 | $1,770 | 44,667 (Direct) | View |
| 2006-03-06 Sale |
2006-03-07 4:25 pm | BIOENVISION INC | BIV | LUCI DAVID P (CFO & Gen. Counsel) | 135,000 | $7.96 | $1,074,668 | 169,054 (Direct) |
View |
| 2006-02-28 Sale |
2006-03-02 11:39 am |
BIOENVISION INC | BIV | LUCI DAVID P (CFO & Gen. Counsel) | 65,000 | $8.572 | $557,160 | 304,054 (Direct) |
View |
| 2004-06-22 Purchase |
2004-06-24 10:53 am | BIOENVISION INC | BIV | LUCI DAVID P (See Exhibit 99.1) | 1,000 | $8.25 | $8,250 | 8,000 (Direct) |
View |
| 2003-11-19 Purchase | 2003-11-25 1:37 pm |
BIOENVISION INC | BIV | LUCI DAVID P (See Exhibit 99.1) | 7,000 | $3.397 | $23,780 | 7,000 (Direct) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2008-12-15- -2009-06-01 Option Award Other | 2009-11-02 2:53 pm |
ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 263,217 | $0.2668 | $70,229 | 263,217 (Direct) | View |
| 2007-07-10 Equity Swap | 2007-07-12 12:07 pm | BIOENVISION INC | BIVN | LUCI DAVID P (EVP & General Counsel) | 310,154 | $5.6 | $1,736,862 | 0 (Direct) | View |
| 2006-11-27 Option Award Tax Withholding | 2006-11-28 12:14 pm | BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 68,900 | $4.94 | $340,366 | 310,154 (Direct) |
View |
| 2006-04-03 Exercise | 2006-04-05 4:33 pm | BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 110,000 | $0.735 | $80,850 | 279,054 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2008-02-04 Purchase |
2009-11-02 2:53 pm |
N/A N/A |
ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 2 | $3 | 33,333 (Direct) |
View |
| 2008-02-04 Purchase |
2009-11-02 2:53 pm |
2008-02-04 2014-02-04 | ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 4,167 | $3.5 | 37,500 (Direct) |
View |
| 2008-05-21 Option Award | 2009-11-02 2:53 pm | 2008-11-21 2018-05-21 | ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 6,000 | $2.9 | 43,500 (Direct) |
View |
| 2009-05-27 Option Award |
2009-11-02 2:53 pm | 2009-05-27 2019-05-27 |
ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 25,000 | $1.38 | 68,500 (Direct) | View |
| 2009-05-27 Option Award |
2009-11-02 2:53 pm | 2009-05-27 2019-05-27 |
ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 20,000 | $1.38 | 88,500 (Direct) | View |
| 2008-04-22 Option Award | 2008-04-24 4:00 pm |
N/A 2018-04-22 |
MACROCHEM CORP | MACH.OB | LUCI DAVID P (Pres. & Chief Business Officer Director) | 2,290,000 | $0.3 | 2,590,000 (Direct) | View |
| 2007-01-04 Option Award |
2007-01-08 2:55 pm | 2007-07-04 2017-01-04 |
ACCESS PHARMACEUTICALS INC | ACCP.OB | LUCI DAVID P (Director) | 25,000 | $2.99 | 25,000 (Direct) |
View |
| 2007-01-03 Option Award |
2007-01-05 2:41 pm |
N/A 2017-01-03 |
BIOENVISION INC | BIVN | LUCI DAVID P (EVP & Gen. Counsel) | 140,000 | $4.6 | 585,000 (Direct) | View |
| 2006-04-03 Exercise | 2006-04-05 4:33 pm | 2006-03-31 2013-03-31 |
BIOENVISION INC | BIVN | LUCI DAVID P (CFO & Gen. Counsel) | 110,000 | $0.735 | 445,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sun, 22 Nov 2009 02:08:37 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |